Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.71 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.70 |
| ▸ | ALPI | P09923 | 1/20 | 0.70 |
| ▸ | PKM | P14618 | 1/20 | 0.70 |
| ▸ | XIAP | P98170 | 1/20 | 0.70 |
| ▸ | HIF1A | Q16665 | 5/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.59 |
| ▸ | USP2 | O75604 | 1/20 | 0.59 |
| ▸ | EGFR | P00533 | 1/20 | 0.59 |
| ▸ | LCK | P06239 | 1/20 | 0.59 |
| ▸ | FYN | P06241 | 1/20 | 0.59 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.59 |
| ▸ | HTR2A | P28223 | 1/20 | 0.59 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.59 |
| ▸ | RECQL | P46063 | 1/20 | 0.59 |
| ▸ | TPH1 | P17752 | 1/20 | 0.59 |
| ▸ | GRB2 | P62993 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL296278 | 1.00 | SLC7A5 (0.71) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL503768 | 1.00 | SLC7A5 (0.71) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL2310526 | 0.91 | SLC7A5 (0.83) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL27913268 | 0.88 | SLC7A5 (0.77) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL16581271 | 0.85 | SLC7A5 (0.74) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL156189 | 0.85 | SLC7A5 (0.74) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL837014 | 0.85 | SLC7A5 (0.74) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL1505730 | 0.84 | SLC7A5 (0.67) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL28052750 | 0.84 | SLC7A5 (0.67) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL3670851 | 0.83 | SLC7A5 (0.71) | SLC7A5PTGS1ALPIPKMXIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 480 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025094171-A1 | SUPERHYDROPHOBIC COATING | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2025-05-08 | — | — | WO | claimed |
| EP-4401555-A1 | ANTIMICROBIAL PEPTIDES | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) | 2024-07-24 | — | — | EP | claimed |
| WO-2023042201-A1 | ANTIMICROBIAL PEPTIDES | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2023-03-23 | — | — | WO | claimed |
| CN-105143245-B | Anti-scaling material | 耶路撒冷希伯来大学伊森姆研究发展有限公司 | 2021-02-05 | — | — | CN | claimed |
| EP-2951195-B1 | ANTIFOULING MATERIALS | YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD (IL) | 2020-02-19 | — | — | EP | claimed |
| EP-3374520-A1 | BIOSENSORS | Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. (IL) | 2018-09-19 | — | — | EP | claimed |
| WO-2017081684-A1 | BIOSENSORS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) | 2017-05-18 | — | — | WO | claimed |
| US-9631100-B2 | Antifouling materials | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2017-04-25 | — | — | US | claimed |
| US-20150368480-A1 | ANTIFOULING MATERIALS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) | 2015-12-24 | — | — | US | claimed |
| CN-105143245-A | Anti-scaling material | YISSUM RES DEV CO | 2015-12-09 | — | — | CN | claimed |
| US-20060247173-A1 | Alpha-conotoxin peptides | THE UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2006-11-02 | — | — | US | claimed |
| WO-2006064133-A2 | NOVEL MULTIMERIC CD40 LIGANDS, METHOD FOR PREPARING SAME AND USE THEREOF FOR PREPARING DRUGS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2006-06-22 | — | — | WO | claimed |
| EP-1282418-B1 | USE OF PYRAZOLE DERIVATIVES FOR TREATING INFERTILITY | APPLIED RESEARCH SYSTEMS (AN) | 2005-08-17 | — | — | EP | claimed |
| US-6914069-B2 | Pharmaceutically active compounds and methods of use | APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) | 2005-07-05 | — | — | US | claimed |
| EP-1159288-A4 | ALPHA-CONOTOXIN PEPTIDES | UNIV UTAH RES FOUND (US) | 2005-06-01 | — | — | EP | claimed |
| US-20040204362-A1 | Alpha-conotoxin peptides | THE UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2004-10-14 | — | — | US | claimed |
| US-6797808-B1 | FOUND NATURALLY IN VENOM OF THE CONE SNAILS; HAVE SPECIFICITY FOR NEURONAL NICOTINIC ACETYLCHOLINE RECEPTORS; FOR TREATING CARDIOVASCULAR, GASTRIC MOTILITY, AND MOOD DISORDERS, URINARY INCONTINENCE, NICOTINE ADDICTION, AND SMALL CELL LUNG CANCER | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2004-09-28 | — | — | US | claimed |
| US-20030050435-A1 | Alpha-conotoxin peptides | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2003-03-13 | — | — | US | claimed |
| EP-1159288-A1 | ALPHA-CONOTOXIN PEPTIDES | University of Utah Research Foundation (US) | 2001-12-05 | — | — | EP | claimed |
| WO-2000043409-A2 | ALPHA-CONOTOXIN PEPTIDES | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2000-07-27 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150368480-A1 | ANTIFOULING MATERIALS | PFAS, FLNB, FLNA | SLC7A5 2272/4885PTGS1 2521/4885ALPI 4730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.